BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22343228)

  • 21. Screening postmenopausal women for ovarian cancer: a systematic review.
    Fung MF; Bryson P; Johnston M; Chambers A;
    J Obstet Gynaecol Can; 2004 Aug; 26(8):717-28. PubMed ID: 15307976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for ovarian cancer in the general population.
    Chu CS; Rubin SC
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):307-20. PubMed ID: 16364690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral oophorectomy in asymptomatic women over 50 years old selected by ovarian cancer screening.
    Hayashi H; Yaginuma Y; Kitamura S; Saitou Y; Miyamoto T; Komori H; Wada K; Ishikawa M
    Gynecol Obstet Invest; 1999; 47(1):58-64. PubMed ID: 9852393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The screening and diagnosis of ovarian cancer].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 1998; 37(3):54-6. PubMed ID: 10204273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian cancer screening.
    Alexander-Sefre F; Menon U; Jacobs IJ
    Hosp Med; 2002 Apr; 63(4):210-3. PubMed ID: 11995270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer screening.
    Rosenthal A; Jacobs I
    Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for ovarian cancer: a systematic review.
    Bell R; Petticrew M; Luengo S; Sheldon TA
    Health Technol Assess; 1998; 2(2):i-iv, 1-84. PubMed ID: 9561894
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for ovarian cancer.
    Anderiesz C; Quinn MA
    Med J Aust; 2003 Jun; 178(12):655-6. PubMed ID: 12797860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
    Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
    Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is it possible to have organized screening for ovarian cancer?].
    Navone R; Montanari G
    Pathologica; 2003 Apr; 95(2):67-70. PubMed ID: 12768874
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific keynote: ovarian cancer risk assessment and the potential for early detection.
    Urban N
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S75-9; discussion S80-3. PubMed ID: 12586091
    [No Abstract]   [Full Text] [Related]  

  • 35. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cancer screening.
    Mackey SE; Creasman WT
    J Clin Oncol; 1995 Mar; 13(3):783-93. PubMed ID: 7884436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
    Pinsky PF; Zhu C; Skates SJ; Black A; Partridge E; Buys SS; Berg CD
    Int J Cancer; 2013 May; 132(9):2127-33. PubMed ID: 23065684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population.
    Stewart SL; Rim SH; Gelb CA
    Health Educ Behav; 2012 Feb; 39(1):57-66. PubMed ID: 21680807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for ovarian cancer: a pilot randomised controlled trial.
    Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
    Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.